Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Targeting specific T cells may help treat alopecia areata.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Lung immune cells can be trained to better fight infections after a virus.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

CXCR3+ T cells and B cells drive skin disease and hair loss in lupus, with potential targets identified for treatment.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Autoimmune reactions may cause both alopecia areata and HAM.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Skin stem cells help create protective immune cells during wound healing.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

BerEP4 and CD34 staining can help tell apart tricholemmoma from basal cell carcinoma.

People with Alopecia areata have higher levels of certain T regulatory cells in their blood.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

Enhancing immune response can improve cancer treatment effectiveness.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

The role of γδT-cells in causing alopecia areata remains unclear.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.